
    
      Patients will be treated for a total of 6 cycles.For patients responding or who have stable
      disease following cycle 6, treatment may continue until one of the following criteria
      applies:

        -  Inter-current illness that prevent further administration of treatment

        -  Unacceptable adverse event(s)

        -  Participant decides to withdraw from the study,

        -  general or specific changes in the participant's condition render the participant
           unacceptable for further treatment in the judgment of the investigator.

        -  Evidence of disease progression by international working Group (IWG) 2006 criteria.

        -  participants who wish not to continue treatment at time of disease assessment at end of
           cycle 6 will complete their end of treatment visit upon completion of cycle 6
    
  